Načítá se...
Busulfan Pharmacokinetics and Precision Dosing: Are Patients with Fanconi Anemia Different?
It is well known that pharmacokinetics (PK) guided busulfan (BU) dosing increases engraftment rates and lowers hepatotoxicity in patients undergoing hematopoietic cell transplantation (HCT). However, there are no published PK data in patients with Fanconi anemia (FA) who are known to have baseline D...
Uloženo v:
| Vydáno v: | Biol Blood Marrow Transplant |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7219959/ https://ncbi.nlm.nih.gov/pubmed/31326610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.07.014 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|